
Welcome to the Bayer AI in Radiology Resource Hub
Here you'll find a library of helpful articles, webinars, eBooks, and presentations
addressing current topics in the use of AI in Radiology.
Enjoy, and check back often as new resources are added.


The Complete Guide to Artificial Intelligence
The healthcare industry potentially has much to gain from incorporating the use of AI, and radiology has been at the forefront of harnessing AI's potential.
This eBook covers:
-
How AI can address workflow issues in radiology departments
-
Ways to overcome the challenges of integrating AI into workflows

Artificial Intelligence in Medical Imaging: What, How, and Why?
Explore how AI in medical imaging could provide unique insights beyond traditional methods while being faster and automated without human interaction.
This eBook covers:
-
Current usage of AI in imaging and considerations for the future of AI in Radiology
-
Funding, adoption, and regulatory landscape

Artificial Intelligence Imaging Applications in Neurology
This eBook outlines the most common applications of AI in neuroradiology and discusses the evidence behind them.
This eBook covers:
-
AI support in the diagnosis of conditions such as stroke and intracranial hemorrhage
-
AI applications that monitor the progression of neurological conditions

Improving Cancer Screening: How AI Empowers Radiologists
Learn how the use of AI-based tools for cancer screening holds promise for mitigating the lack of trained radiologists.
This eBook covers:
-
Research about algorithms that can be used in detecting Colorectal cancer, Hepatocellular carcinoma, and Prostate cancer
-
Systems based on AI that have been incorporated at various stages in the breast cancer screening process.


Moving from Data Governance to AI Governance: Three ways to get Started
The FDA has now cleared more than 500 healthcare AI algorithms, and the number is growing each day.1 As healthcare systems embrace this new technology, AI Governance is emerging as an essential, critical role.
If your healthcare organization is considering an AI Governance program, here are three steps to get the process started.
1 FDA has now cleared more than 500 healthcare AI algorithms (healthexec.com)


Winning the Hearts and Minds. AI and Change Management
Access insights on streamlining transitions, addressing resistance to change, and optimizing AI’s potential to impact patient care.

Bias in Machine Learning
The field of radiology has witnessed a significant surge in interest in AI. Nevertheless, uncertainty lingers concerning the potential for bias in machine learning training.

How to Demonstrate Clinical Utility of AI
This webinar discusses how to demonstrate the clinical utility of AI and whether this can lead to successful reimbursements.

To Pay or Not to Pay for the Artificial Intelligence Applications in Radiology
Healthcare providers and payors need a set of criteria to decide the payment for AI applications in Radiology. The speakers in this webinar propose a framework to help serve as a guide for payers.

Artificial Intelligence in Radiology and the Considerations for Regulation
Explore recommendations surrounding the integration of AI solutions at healthcare institutions through a webinar addressing the challenges and opportunities that arise during AI implementation.

AI in Medical Imaging: The What, How and Why
In this webinar, we explore the current state of AI in medical imaging before, during, and after image acquisition. The speakers discuss funding, adoption, and regulatory landscape and share insights into the future steps and challenges of AI in medical imaging.

The Present and Future of Lung Cancer Screening
This webinar reviews current evidence-based recommendations for lung cancer screening and aims to provide a global perspective on eligibility criteria.
© 2024 Bayer
The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.
BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. Other trademarks and company names mentioned herein are properties of their respective owners.
This is intended to provide information for healthcare professionals and other relevant decision makers in the US. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.
Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information.
You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect
Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.
Last Updated: February 2024